[go: up one dir, main page]

ATE503847T1 - Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten - Google Patents

Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten

Info

Publication number
ATE503847T1
ATE503847T1 AT07849642T AT07849642T ATE503847T1 AT E503847 T1 ATE503847 T1 AT E503847T1 AT 07849642 T AT07849642 T AT 07849642T AT 07849642 T AT07849642 T AT 07849642T AT E503847 T1 ATE503847 T1 AT E503847T1
Authority
AT
Austria
Prior art keywords
multiple sclerosis
kits
methods
probably
diagnosing
Prior art date
Application number
AT07849642T
Other languages
English (en)
Inventor
Anat Achiron
Michael Gurevich
Original Assignee
Tel Hashomer Medical Res Infrastructure & Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tel Hashomer Medical Res Infrastructure & Services Ltd filed Critical Tel Hashomer Medical Res Infrastructure & Services Ltd
Application granted granted Critical
Publication of ATE503847T1 publication Critical patent/ATE503847T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
AT07849642T 2006-12-29 2007-12-27 Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten ATE503847T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87768206P 2006-12-29 2006-12-29
PCT/IL2007/001616 WO2008081434A2 (en) 2006-12-29 2007-12-27 Methods and kits for diagnosis of multiple sclerosis in probable multiple sclerosis subjects

Publications (1)

Publication Number Publication Date
ATE503847T1 true ATE503847T1 (de) 2011-04-15

Family

ID=39365845

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07849642T ATE503847T1 (de) 2006-12-29 2007-12-27 Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten

Country Status (6)

Country Link
US (1) US20100112568A1 (de)
EP (1) EP2121971B1 (de)
AT (1) ATE503847T1 (de)
CA (1) CA2673595A1 (de)
DE (1) DE602007013615D1 (de)
WO (1) WO2008081434A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2191014B1 (de) * 2007-08-13 2013-04-03 Baxter International Inc. Ivig-modulation von chemokinen zur behandlung von multipler sklerose, morbus alzheimer und morbus parkinson
WO2010011965A2 (en) * 2008-07-24 2010-01-28 The Regents Of The University Of California Identifying high risk clinically isolated syndrome patients
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
GB201909619D0 (en) * 2019-07-04 2019-08-21 Univ Oxford Innovation Ltd Methods for diagnosing multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001059063A2 (en) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001087903A2 (en) * 2000-05-18 2001-11-22 Genaissance Pharmaceuticals, Inc. Haplotypes of the acaa1 gene
WO2003081201A2 (en) * 2002-03-21 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
AUPS271902A0 (en) * 2002-05-31 2002-06-20 Griffith University Gene expression and multiple sclerosis

Also Published As

Publication number Publication date
EP2121971A2 (de) 2009-11-25
EP2121971B1 (de) 2011-03-30
WO2008081434A2 (en) 2008-07-10
US20100112568A1 (en) 2010-05-06
WO2008081434A3 (en) 2009-02-12
DE602007013615D1 (de) 2011-05-12
CA2673595A1 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
EP1810026A4 (de) B7-h1 und verfahren zur diagnose, prognose und behandlung von krebs
Agosta et al. The El Escorial criteria: strengths and weaknesses
Donaghy et al. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis
GB201009641D0 (en) Methods of monitoring conditions by sequence analysis
IN2014CN01787A (de)
MX341517B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
BR112018015698A2 (pt) ?métodos diagnósticos e prognósticos para doenças cardiovasculares e eventos?
EP2569635A4 (de) Verfahren zur diagnose und/oder behandlung von enzephalitis oder epilepsie
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
ATE518007T1 (de) Verfahren und vorrichtung zur korrelierung der ebenen von biomarker-produkten mit erkrankungen
MX336835B (es) Metodos y composiciones para el diagnostico y tratamiento de la enfermedad autoinmune secundaria a esclerosis multiple.
WO2011133770A3 (en) Salivary protein markers for detection of breast cancer
MX2017003370A (es) Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica.
WO2008081435A3 (en) Methods and kits for predicting prognosis of multiple sclerosis
EP2573192A4 (de) Verfahren und kit zur diagnose aim-vermittelter erkrankungen
ATE503847T1 (de) Verfahren und kits zur diagnose von multipler sklerose bei wahrscheinlichen multiple-sklerose- patienten
EA201290056A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
EP4524553A3 (de) Diagnostische analyse mit definitiver entwicklung
BRPI0715714A2 (pt) Métodos para diminuir a frequência de emergência de uma infecção viral de hepatite c resistente ao tratamento, para atrasar a emergência de uma infecção viral de hepatite c resistente ao tratamento, para diminuir o nível de resistência de uma infecção viral de hepatite c resistente ao tratamento, para diminuir a emergência de uma infecção viral de hepatite c resistente a hcv-796, para identificar um indivíduo com uma probabilidade diminuída de responder a uma terapia viral anti-hepatite c, para monitorar, diagnosticar ou prognosticar a infecção viral de hepatite c resistente ao tratamento em um paciente, para monitorar o curso de tratamento de uma infecção viral de hepatite c em um paciente, para prognosticar o desenvolvimento de um ainfecção viral de hepatite c resistente ao tratamento em um paciente, para monitorar a infecção viral de hepatite c em um paciente e para diagnosticar o desenvolvimento de uma infecção viral de hepatite ao tratamento em um paciente
EA201290192A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
MX2009006744A (es) Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
MX2012007009A (es) Método para diagnosticar un tumor maligno.
DE602006012033D1 (de) Verfahren zur messung immunsuppressiver tacrolimus-, sirolimus- und cyclosporin-a-komplexe in einer blutprobe
BR112015014232A2 (pt) lesão renal aguda
JP2018536170A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties